A Philadelphia jury awarded $500,000 on Dec. 11 to the plaintiff in the fourth Risperdal trial to go to a verdict.
After about six hours of deliberating, the 12-member jury in Stange v. Janssen Pharmaceuticals found that Janssen Pharmaceuticals negligently failed to warn about the antipsychotic drug, and that the negligence caused the injuries of plaintiff Timothy Stange. While the jury was unanimous on the issues of damages and failure to warn, two jurors found for Janssen on the causation issue.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
